Medicinova Inc. Stock
Medicinova Inc. Stock
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Medicinova Inc..
Based on the current price of 3.22 € the target price of 7 € shows a potential of 117.53% for Medicinova Inc. which would more than double the current price.
Pros and Cons of Medicinova Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicinova Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicinova Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | -0.410% | 10.879% | -0.581% | -54.196% | -30.925% | -70.630% | -94.480% |
| Evolus Inc | -1.110% | 2.890% | -17.972% | -56.585% | -34.679% | -52.848% | -62.723% |
| Sangamo Therapeutics Inc. | 1.000% | -15.105% | -33.193% | -65.067% | -36.535% | -85.093% | -97.648% |
Comments
MediciNova (MNOV) had its "buy" rating reaffirmed by Maxim Group. They now have a $6.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (MNOV) is now covered by HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat